Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asthma management in pregnancy and lactation: A review of current evidence and best practice recommendations.

NPJ primary care respiratory medicine·2026
Same author

Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting.

Journal of Alzheimer's disease : JAD·2025
Same author

Patient and healthcare providers' perspectives on participation in a postpartum pilot trial of venous thromboembolism prophylaxis: a qualitative study.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories.

Journal of the neurological sciences·2025
Same author

Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial.

The Lancet. Haematology·2025
Same author

Benefits of a collaborative approach to service evaluation in urgent care.

Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association·2022

Related Experiment Video

Updated: Mar 22, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K

Some recent advances in multiple sclerosis.

Claire McCarthy1,2, John Thorpe3,4

  • 1Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. c.helliwell@doctors.org.uk.

Journal of Neurology
|April 27, 2016
PubMed
Summary

Recent advances in multiple sclerosis (MS) include better understanding of its genetics and pathogenesis. New classifications and rapidly evolving therapeutics offer practical insights for neurologists.

Keywords:
ClassificationGeneticsMRIMultiple sclerosisTherapy

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.3K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K

Related Experiment Videos

Last Updated: Mar 22, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.3K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K

Area of Science:

  • Neuroimmunology
  • Genetics of neurological disorders
  • Clinical neurology

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Understanding MS pathogenesis and genetics is crucial for developing effective treatments.
  • Recent years have seen significant advancements in MS research.

Purpose of the Study:

  • To review key advances in multiple sclerosis (MS) over the past three years.
  • To summarize recent progress in MS genetics, pathogenesis, and classification.
  • To provide a practical overview of evolving MS therapeutics for clinicians.

Main Methods:

  • Literature review of recent publications on multiple sclerosis.
  • Synthesis of findings related to MS genetics and pathogenesis.
  • Analysis of revised MS phenotype classifications and therapeutic developments.

Main Results:

  • Substantial progress in understanding the genetic underpinnings of MS.
  • Enhanced insights into the complex pathogenesis of MS.
  • Revised classification of MS phenotypes reflecting disease heterogeneity.
  • Rapid evolution in the therapeutic landscape for MS management.

Conclusions:

  • The last three years have yielded significant breakthroughs in MS research.
  • Clinicians benefit from updated knowledge on MS genetics, classification, and treatments.
  • Continued research is vital for further improving MS patient outcomes.